+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Analgesics Market Research Report by Drug Type, Type, Route of Administration, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 223 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5264364
UP TO OFF until Dec 31st 2022
The Global Analgesics Market size was estimated at USD 18.53 billion in 2021, USD 20.11 billion in 2022, and is projected to grow at a CAGR of 8.69% to reach USD 30.56 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Analgesics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the market was studied across Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), and Salicylates.
  • Based on Type, the market was studied across Non-opioids and Opioids.
  • Based on Route of Administration, the market was studied across Intravenous, Oral, Rectal, Topical, and Transdermal.
  • Based on Distribution, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Analgesics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Analgesics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Analgesics Market, including 7T Pharma LLC, Abbott Laboratories, AbbVie Inc., Amphastar Pharmaceuticals, Inc., Aspen Pharmacare Holdings Limited, Astrazeneca PLC, Avir Pharma Inc, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG, Cantrell Drug Company, Cipher Pharmaceuticals Inc., Cipla USA Inc., Claris Life sciences, Eisai Co. Ltd., Exelan Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Fresenius Kabi USA, LLC, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Hospira, Inc., Leucadia Pharmaceuticals, Maruishi Pharmaceutical Co., Ltd., Mylan Institutional LLC, Pacira Pharmaceuticals, Inc., Paion UK Ltd, Pfizer Inc., Piramal Enterprises LTD, Remedy Repack, Sandoz Inc, Septodont, Stat Rx USA, Teva Pharmaceutical Industries Limited, Troikaa Pharmaceuticals Ltd, Vertical Pharmaceuticals, Inc., and West-Ward Pharmaceuticals Corp.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Analgesics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Analgesics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Analgesics Market?
4. What is the competitive strategic window for opportunities in the Global Analgesics Market?
5. What are the technology trends and regulatory frameworks in the Global Analgesics Market?
6. What is the market share of the leading vendors in the Global Analgesics Market?
7. What modes and strategic moves are considered suitable for entering the Global Analgesics Market?
Frequently Asked Questions about the Global Analgesics Market

What is the estimated value of the Global Analgesics Market?

The Global Analgesics Market was estimated to be valued at $18.53 Billion in 2021.

What is the growth rate of the Global Analgesics Market?

The growth rate of the Global Analgesics Market is 8.6%, with an estimated value of $30.56 Billion by 2027.

What is the forecasted size of the Global Analgesics Market?

The Global Analgesics Market is estimated to be worth $30.56 Billion by 2027.

Who are the key companies in the Global Analgesics Market?

Key companies in the Global Analgesics Market include 7T Pharma LLC, Abbott Laboratories, AbbVie Inc., Amphastar Pharmaceuticals, Inc., Aspen Pharmacare Holdings Limited, Astrazeneca PLC, Avir Pharma Inc, B. Braun Melsungen AG and Boehringer Ingelheim International GmbH.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
5.1.1.2. Frequent pain and aches encountered by the aging population
5.1.1.3. Cost-efficiency of OTC analgesics drugs
5.1.2. Restraints
5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D by the public & private sectors
5.1.3.2. Surge in popularity of personalized medicine
5.1.4. Challenges
5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
5.2. Cumulative Impact of COVID-19
6. Analgesics Market, by Drug Type
6.1. Introduction
6.2. Acetaminophen
6.3. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
6.4. Salicylates
7. Analgesics Market, by Type
7.1. Introduction
7.2. Non-opioids
7.3. Opioids
8. Analgesics Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.4. Rectal
8.5. Topical
8.6. Transdermal
9. Analgesics Market, by Distribution
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Analgesics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Analgesics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Analgesics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 7T Pharma LLC
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Abbott Laboratories
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. AbbVie Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Amphastar Pharmaceuticals, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Aspen Pharmacare Holdings Limited
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Astrazeneca PLC
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Avir Pharma Inc
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. B. Braun Melsungen AG
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Baxter International Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Boehringer Ingelheim International GmbH
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Braun Melsungen AG
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Cantrell Drug Company
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Cipher Pharmaceuticals Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Cipla USA Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Claris Life sciences
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Eisai Co. Ltd.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Exelan Pharmaceuticals, Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. F. Hoffmann-La Roche Ltd
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Fresenius Kabi USA, LLC
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Glenmark Pharmaceuticals Limited
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Hikma Pharmaceuticals PLC
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Hospira, Inc.
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Leucadia Pharmaceuticals
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Maruishi Pharmaceutical Co., Ltd.
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Mylan Institutional LLC
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
14.26. Pacira Pharmaceuticals, Inc.
14.26.1. Business Overview
14.26.2. Key Executives
14.26.3. Product & Services
14.27. Paion UK Ltd
14.27.1. Business Overview
14.27.2. Key Executives
14.27.3. Product & Services
14.28. Pfizer Inc.
14.28.1. Business Overview
14.28.2. Key Executives
14.28.3. Product & Services
14.29. Piramal Enterprises LTD
14.29.1. Business Overview
14.29.2. Key Executives
14.29.3. Product & Services
14.30. Remedy Repack
14.30.1. Business Overview
14.30.2. Key Executives
14.30.3. Product & Services
14.31. Sandoz Inc
14.31.1. Business Overview
14.31.2. Key Executives
14.31.3. Product & Services
14.32. Septodont
14.32.1. Business Overview
14.32.2. Key Executives
14.32.3. Product & Services
14.33. Stat Rx USA
14.33.1. Business Overview
14.33.2. Key Executives
14.33.3. Product & Services
14.34. Teva Pharmaceutical Industries Limited
14.34.1. Business Overview
14.34.2. Key Executives
14.34.3. Product & Services
14.35. Troikaa Pharmaceuticals Ltd
14.35.1. Business Overview
14.35.2. Key Executives
14.35.3. Product & Services
14.36. Vertical Pharmaceuticals, Inc.
14.36.1. Business Overview
14.36.2. Key Executives
14.36.3. Product & Services
14.37. West-Ward Pharmaceuticals Corp
14.37.1. Business Overview
14.37.2. Key Executives
14.37.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANALGESICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANALGESICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL ANALGESICS MARKET DYNAMICS
FIGURE 11. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG TYPE, 2027
FIGURE 14. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 18. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 20. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 23. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 25. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, 2018-2027 (USD BILLION)
FIGURE 28. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, 2018-2027 (USD BILLION)
FIGURE 30. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 31. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION, 2027
FIGURE 33. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 34. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 36. AMERICAS ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 39. AMERICAS ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 40. ARGENTINA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. BRAZIL ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. CANADA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. MEXICO ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. UNITED STATES ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 46. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 47. UNITED STATES ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 48. ASIA-PACIFIC ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 51. ASIA-PACIFIC ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 52. AUSTRALIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. CHINA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. INDIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. INDONESIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. JAPAN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. MALAYSIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. PHILIPPINES ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. SINGAPORE ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. SOUTH KOREA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. TAIWAN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. THAILAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. VIETNAM ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 68. DENMARK ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. EGYPT ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. FINLAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. FRANCE ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. GERMANY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. ISRAEL ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. ITALY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. NETHERLANDS ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. NIGERIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. NORWAY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. POLAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. QATAR ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. RUSSIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. SAUDI ARABIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. SOUTH AFRICA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. SPAIN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. SWEDEN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. SWITZERLAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. TURKEY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. UNITED KINGDOM ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. GLOBAL ANALGESICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 90. GLOBAL ANALGESICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 91. GLOBAL ANALGESICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL ANALGESICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2027 (USD BILLION)
TABLE 11. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 43. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD BILLION)
TABLE 44. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 45. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 46. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 49. AMERICAS ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 50. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 51. AMERICAS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 52. AMERICAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 53. AMERICAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 54. AMERICAS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 55. ARGENTINA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 56. ARGENTINA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 57. ARGENTINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 58. ARGENTINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 59. ARGENTINA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 60. BRAZIL ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 61. BRAZIL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 62. BRAZIL ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 63. BRAZIL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 64. BRAZIL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 65. CANADA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 66. CANADA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 67. CANADA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 68. CANADA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 69. CANADA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 70. MEXICO ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 71. MEXICO ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 72. MEXICO ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 73. MEXICO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 74. MEXICO ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 75. UNITED STATES ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 76. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 77. UNITED STATES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 78. UNITED STATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 79. UNITED STATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 80. UNITED STATES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 81. ASIA-PACIFIC ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 82. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 83. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 84. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 86. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 87. AUSTRALIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 88. AUSTRALIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 89. AUSTRALIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 90. AUSTRALIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 91. AUSTRALIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 92. CHINA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 93. CHINA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 94. CHINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 95. CHINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 96. CHINA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 97. INDIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 98. INDIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 99. INDIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 100. INDIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 101. INDIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 102. INDONESIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 103. INDONESIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 104. INDONESIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 105. INDONESIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 106. INDONESIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 107. JAPAN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 108. JAPAN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 109. JAPAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 110. JAPAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 111. JAPAN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 112. MALAYSIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 113. MALAYSIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 114. MALAYSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 115. MALAYSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 116. MALAYSIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 117. PHILIPPINES ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 118. PHILIPPINES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 119. PHILIPPINES ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 120. PHILIPPINES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 121. PHILIPPINES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 122. SINGAPORE ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 123. SINGAPORE ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 124. SINGAPORE ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 125. SINGAPORE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 126. SINGAPORE ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 127. SOUTH KOREA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 128. SOUTH KOREA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 129. SOUTH KOREA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 130. SOUTH KOREA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 131. SOUTH KOREA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 132. TAIWAN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 133. TAIWAN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 134. TAIWAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 135. TAIWAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 136. TAIWAN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 137. THAILAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 138. THAILAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 139. THAILAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 140. THAILAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 141. THAILAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 142. VIETNAM ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 143. VIETNAM ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 144. VIETNAM ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 145. VIETNAM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 146. VIETNAM ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 153. DENMARK ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 154. DENMARK ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 155. DENMARK ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 156. DENMARK ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 157. DENMARK ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 158. EGYPT ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 159. EGYPT ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 160. EGYPT ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 161. EGYPT ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 162. EGYPT ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 163. FINLAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 164. FINLAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 165. FINLAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 166. FINLAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 167. FINLAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 168. FRANCE ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 169. FRANCE ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 170. FRANCE ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 171. FRANCE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 172. FRANCE ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 173. GERMANY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 174. GERMANY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 175. GERMANY ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 176. GERMANY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 177. GERMANY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 178. ISRAEL ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 179. ISRAEL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 180. ISRAEL ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 181. ISRAEL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 182. ISRAEL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 183. ITALY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 184. ITALY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 185. ITALY ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 186. ITALY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 187. ITALY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 188. NETHERLANDS ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 189. NETHERLANDS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 190. NETHERLANDS ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 191. NETHERLANDS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 192. NETHERLANDS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 193. NIGERIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 194. NIGERIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 195. NIGERIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 196. NIGERIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 197. NIGERIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 198. NORWAY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 199. NORWAY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 200. NORWAY ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 201. NORWAY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 202. NORWAY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 203. POLAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 204. POLAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 205. POLAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 206. POLAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 207. POLAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 208. QATAR ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 209. QATAR ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 210. QATAR ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 211. QATAR ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 212. QATAR ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 213. RUSSIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 214. RUSSIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 215. RUSSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 216. RUSSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 217. RUSSIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 218. SAUDI ARABIA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 219. SAUDI ARABIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 220. SAUDI ARABIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 221. SAUDI ARABIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 222. SAUDI ARABIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 223. SOUTH AFRICA ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 224. SOUTH AFRICA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 225. SOUTH AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 226. SOUTH AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 227. SOUTH AFRICA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 228. SPAIN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 229. SPAIN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 230. SPAIN ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 231. SPAIN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 232. SPAIN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 233. SWEDEN ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 234. SWEDEN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 235. SWEDEN ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 236. SWEDEN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 237. SWEDEN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 238. SWITZERLAND ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 239. SWITZERLAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 240. SWITZERLAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 241. SWITZERLAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 242. SWITZERLAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 243. TURKEY ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 244. TURKEY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 245. TURKEY ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 246. TURKEY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 247. TURKEY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 248. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 249. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 250. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 251. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 252. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 253. UNITED KINGDOM ANALGESICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 254. UNITED KINGDOM ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2027 (USD BILLION)
TABLE 255. UNITED KINGDOM ANALGESICS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 256. UNITED KINGDOM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 257. UNITED KINGDOM ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 258. GLOBAL ANALGESICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 259. GLOBAL ANALGESICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 260. GLOBAL ANALGESICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 261. GLOBAL ANALGESICS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 262. GLOBAL ANALGESICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 263. GLOBAL ANALGESICS MARKET MERGER & ACQUISITION
TABLE 264. GLOBAL ANALGESICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 265. GLOBAL ANALGESICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 266. GLOBAL ANALGESICS MARKET INVESTMENT & FUNDING
TABLE 267. GLOBAL ANALGESICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 268. GLOBAL ANALGESICS MARKET: LICENSE & PRICING

Companies Mentioned

  • 7T Pharma LLC
  • Abbott Laboratories
  • AbbVie Inc.
  • Amphastar Pharmaceuticals, Inc.
  • Aspen Pharmacare Holdings Limited
  • Astrazeneca PLC
  • Avir Pharma Inc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Braun Melsungen AG
  • Cantrell Drug Company
  • Cipher Pharmaceuticals Inc.
  • Cipla USA Inc.
  • Claris Life sciences
  • Eisai Co. Ltd.
  • Exelan Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi USA, LLC
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Hospira, Inc.
  • Leucadia Pharmaceuticals
  • Maruishi Pharmaceutical Co., Ltd.
  • Mylan Institutional LLC
  • Pacira Pharmaceuticals, Inc.
  • Paion UK Ltd
  • Pfizer Inc.
  • Piramal Enterprises LTD
  • Remedy Repack
  • Sandoz Inc
  • Septodont
  • Stat Rx USA
  • Teva Pharmaceutical Industries Limited
  • Troikaa Pharmaceuticals Ltd
  • Vertical Pharmaceuticals, Inc.
  • West-Ward Pharmaceuticals Corp

Methodology

Loading
LOADING...